Dashboard Screener SEC Filings Government Disclosures Contracts + Permits Earnings + IPOs Treasury Yields ETF Explorer Short Volume COT Positioning

Privacy Policy Terms of Service About

10-KT/A — KalVista Pharmaceuticals, Inc. | Tormere

← 10-K / 10-Q

10-KT/AKALV

KalVista Pharmaceuticals, Inc.

Filed 2026-04-30Period ending 2025-12-31

EDGAR ↗All periods →

Income Statement

Line Item	2025-12-31	Y/Y
Net Income	-$183.4M	—